BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock Fundamental Analysis
BrightSpring Health Services, Inc. Common Stock (BTSG) shows weak financial fundamentals with a PE ratio of 63.76, profit margin of 1.04%, and ROE of 7.52%. The company generates $11.1B in annual revenue with strong year-over-year growth of 27.65%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 44.5/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BTSG's fundamental strength across five key dimensions:
Efficiency Score
WeakBTSG struggles to generate sufficient returns from assets.
Valuation Score
ModerateBTSG shows balanced valuation metrics.
Growth Score
ExcellentBTSG delivers strong and consistent growth momentum.
Financial Health Score
ModerateBTSG shows balanced financial health with some risks.
Profitability Score
WeakBTSG struggles to sustain strong margins.
Key Financial Metrics
Is BTSG Expensive or Cheap?
P/E Ratio
BTSG trades at 63.76 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BTSG's PEG of 0.91 indicates potential undervaluation.
Price to Book
The market values BrightSpring Health Services, Inc. Common Stock at 4.54 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 10.82 times EBITDA. This signals the market has high growth expectations.
How Well Does BTSG Make Money?
Net Profit Margin
For every $100 in sales, BrightSpring Health Services, Inc. Common Stock keeps $1.04 as profit after all expenses.
Operating Margin
Core operations generate 2.14 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.52 in profit for every $100 of shareholder equity.
ROA
BrightSpring Health Services, Inc. Common Stock generates $2.14 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
BrightSpring Health Services, Inc. Common Stock generates limited operating cash flow of $312.10M, signaling weaker underlying cash strength.
Free Cash Flow
BrightSpring Health Services, Inc. Common Stock generates weak or negative free cash flow of $246.74M, restricting financial flexibility.
FCF Per Share
Each share generates $1.37 in free cash annually.
FCF Yield
BTSG converts 3.74% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
63.76
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.91
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.54
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.59
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.48
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.79
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How BTSG Stacks Against Its Sector Peers
| Metric | BTSG Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 63.76 | 29.43 | Worse (Expensive) |
| ROE | 7.52% | 800.00% | Weak |
| Net Margin | 1.04% | -20145.00% (disorted) | Weak |
| Debt/Equity | 1.48 | 0.30 | Weak (High Leverage) |
| Current Ratio | 1.79 | 4.64 | Neutral |
| ROA | 2.14% | -17936.00% (disorted) | Weak |
BTSG outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews BrightSpring Health Services, Inc. Common Stock's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-90.90%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
99.09%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-99.22%
Industry Style: Defensive, Growth, Innovation
Declining